Navigation Links
Breast Cancer Treatment Is Reduced to One Week
Date:1/29/2008

Chicago-Area Community Hospital to Offer New Clinical Study to Breast

Cancer Patients

EVERGREEN PARK, Ill., Jan. 29 /PRNewswire/ -- Little Company of Mary Hospital and Health Care Centers in Evergreen Park, Illinois, near Chicago (http://www.PursuingPainFreeCancer.org/breastcancer), has announced it will offer a new clinical study by Xoft using electronic brachytherapy for the treatment of early stage breast cancer. The study involves the delivery of a safer form of radiation to breast cancer patients that will reduce the average treatment time from seven weeks to just one week.

Axxent Electronic Brachytherapy System uses a small electronic, low-energy X-ray source that delivers controlled radiation treatment directly to the targeted area. It is similar to another known procedure called Mammosite, but uses a different type of radiation. The Electronic Brachytherapy System uses a balloon-like device, which is implanted at the targeted area. Twice a day for five days, the balloon is expanded and a miniature X-ray tube is inserted.

Little Company of Mary is the first community hospital in Illinois to offer the study, joining only nine other sites in the country that offer the treatment. "I am proud to bring this new technology to Little Company of Mary and offer the women in Chicago's Southwest community a new and safer form of radiation therapy for the treatment of breast cancer," said radiation oncologist Dr. Adam Dickler. Dr. Dickler was the study's principal investigator when it was first offered in Illinois prior to arriving at Little Company of Mary in October.

Dr. Dickler says the major benefit for patients is the largely reduced treatment time, which would help many women receive the treatment they need without having to undergo therapy for seven weeks. A key component that sets this therapy apart is that electronic br
'/>"/>

SOURCE Little Company of Mary Hospital and Health Care Centers
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
2. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
5. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
6. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
7. New Drug Combination is Able to Eradicate Breast Metastases in Mice
8. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
9. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
10. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
11. Anastrozole Confirmed Superior in Breast Cancer Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Feb. 9 Palatin Technologies, ... the completion of first cohort dosing in a ... treatment for sexual dysfunction.  The primary endpoint in ... pressure effects of subcutaneous bremelanotide in men between ... also evaluate consistency of plasma exposure of bremelanotide ...
(Date:2/9/2010)... LAUSANNE , Switzerland , February ... Swiss-based global biopharmaceutical group of companies with,a ... that target unmet medical,needs, today announced the ... for the development, manufacture and commercialisation of ... inhibitor with a,potent anti-hepatitis C virus (HCV) ...
(Date:2/8/2010)... Calif. , Feb. 8 PreXion, ... quality 3D Cone Beam Imaging systems for dentistry, today ... as Director of Marketing. ,, PreXion President/COO ... Keith on our senior management team and I look ... extensive sales and marketing leadership, experience and success in ...
Breaking Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3PreXion, Inc. Announces Appointment of Director of Marketing 2Icahn Indicates That Biogen Board Refuses To Close Polls 12450 1MDCT angiography leads to successful treatment of severely blocked arteries in the legs 47804 1Biologists consider unifying framework to explain evolutionary puzzles 8709 1Biologists consider unifying framework to explain evolutionary puzzles 8709 2
... Inc. (OTC Bulletin Board: PLCSF), a company focused on ... that the first data from its pilot safety trial ... at the American College of Cardiology Annual Conference, on ... Florida. The poster will be presented by Dr. ...
... Abstracts Will Be Featured at Annual Kidney Care MeetingEL ... provider of kidney care services for those diagnosed with ... DaVita Clinical Research(R), today announced that company representatives will ... Spring Clinical Meetings scheduled for March 25-29, 2009 in ...
Other Medicine Technology:RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 2RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 2DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 4DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 5
(Date:2/9/2010)... Age, gender, genetics affect odds of remaining recurrence-free, research ... U.S. scientists have discovered there are genetic profiles that ... cancers, and those profiles differ depending on the age ... genetic and clinical data from 787 patients who were ... or above age 70). The findings are published in ...
(Date:2/9/2010)... folic acid, high blood pressure restrict fetal growth, study ... lifestyle habits you bring into pregnancy can have lasting ... A Dutch study found that women who smoked, had ... early pregnancy had babies that were smaller in the ... of complications later. , "Our study demonstrates that several ...
(Date:2/9/2010)... The following statement is ... M.D., President, American Medical Association: ,, (Logo: ... Medical Association is pleased to support First ... Let,s Move Campaign. As the nation,s largest ... address obesity and are committed to reenergizing ...
(Date:2/9/2010)... in captivity primarily for their skins, but some restaurants ... A study shows that eating these animals can have ... eating this ,delicacy., , Parasites, bacteria and viruses, and ... residues of veterinary drugs- eating reptile meat can cause ... a study published in the International Journal of ...
(Date:2/9/2010)... Dr. Franois Robert, a researcher at the Institut de ... team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute ... mapped all the fragile sites of a living organism, ... used by the researchers can be applied to humans. ... scientific journal Nature Structural and Molecular Biology . ...
Breaking Medicine News(10 mins):Health News:Genes Play Role in Prognosis With Non-Small Cell Lung Cancers 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Study carried out into biological risks of eating reptiles 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3
... study neurosurgeons say they are now convinced that helmets ... the past have suggested wearing helmets during a motorcycle ... of skull base and cervical-spine (or neck) injuries secondary ... researchers to study whether helmets harm or hurt adolescent ...
... women with leukemia who died after receiving a bone marrow ... shows evidence of the transplanted // cells up to six ... marrow cells were actually acting as stem cells -- basic ... the body, and once thought to be found only in ...
... by adding more calcium to the diet may help reduce ... ,In a study of more than 95,000 women who never ... the eight years of the study. Women who consumed the ... stones compared to women who consumed the least amount. The ...
... United States. Investigators have been tracking the health of men and ... factors might impact their risk for heart disease and stroke. In ... and without a history of stroke.About 20 percent of the people ... of those who didn’t have a stroke. ,A good way ...
... suffer a stroke. About one-third of those strokes are recurrent. ... that consume lots of energy, such as dressing, bathing, walking ... survivors should be urged to exercise more at least 20 ... can help reduce the risk of another stroke. Strength training, ...
... a human papillomavirus ( HPV ) vaccination with cervical cancer ... all cervical cancers. According to a recent study it was ... caused by HPV, and 9 percent are preceded by persistent ... detect cervical cancer but it is not available to all ...
Other Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: